Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."

TSX:MSL - Post Discussion

View:
Post by thedave2006 on Aug 15, 2016 7:31am

Q ok?

a loss is a loss but revs and ebidta is improving.

https://ca.finance.yahoo.com/news/merus-labs-reports-fiscal-q3-110000202.html
Comment by Volcom370 on Aug 15, 2016 7:37am
they lowered guidance, hope that doesn't hurt us to much.
Comment by peter75 on Aug 15, 2016 8:04am
They have not lowered quidence
Comment by Volcom370 on Aug 15, 2016 8:15am
Fiscal 2016 Guidance Merus is reiterating its guidance. The Company anticipates fiscal 2016 adjusted EBITDA, without consideration of additional acquisitions, to be in the $47 million to $50 million range. Our pipeline remains robust, and we continue to look at a wide spectrum of opportunities including legacy products and growth assets. Now became : Higher than planned expenses during the second ...more  
Comment by kuatolives on Aug 15, 2016 8:18am
Is that a 4 cent/share loss? Not a holder but I follow the company.
Comment by lscfa on Aug 15, 2016 9:27am
A loss is not a loss, dumbass....eps is - $0.04 but cfps is + $0.07....also, mgmt continues to understate guidance by ignore the $8 million in manufacturing savings set to start  at year end.....
Comment by Volcom370 on Aug 15, 2016 9:48am
Did you really just call another shareholder a dumbass for asking a question ?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities